Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 12;15(3):e0229883. doi: 10.1371/journal.pone.0229883

Prevalence of malnutrition and associated factors among adult patients on antiretroviral therapy follow-up care in Jimma Medical Center, Southwest Ethiopia

Dawit Wolde Daka 1,*, Meskerem Seboka Ergiba 1
Editor: Simeon-Pierre Choukem2
PMCID: PMC7067416  PMID: 32163485

Abstract

Background

Malnutrition especially undernutrition is the main problem that is seen over people living with HIV/AIDS and can occur at any age. Multiple factors contributed to undernutrition of HIV/AIDS patients and it need immediate identification and prompt action. The objective of this study was to assess the nutritional status of patients and identify factors associated with undernutrition among HIV/AIDS patients on follow-up care in Jimma medical center, Southwest Ethiopia.

Methods

A cross-sectional study design was conducted from March-April 2016. Data were collected retrospectively from clinical records of HIV/AIDS patients enrolled for follow up care in ART clinic from June 2010 to January 2016. Bivariate and multivariate logistic regression analysis were performed to identify independent predictor of undernutrition.

Results

Data of 1062 patients were included in the study. The prevalence of undernutrition (BMI<18.5 kg/m2) and overweight or obesity were 34% and 9%, respectively. Out of undernourished patients, severely malnourished patients (BMI<16 kg/m2) accounted of 9%. Undernutrition was more likely among widowed patients (AOR = 1.7, 95% CI, 1.03–2.79), patients with no access to water supply (AOR = 1.69, 95% CI, 1.16–2.47) and patients in the WHO clinical stage of three (AOR = 2.0, 95% CI, 1.33–2.97) and four (AOR = 3.0, 95% CI, 1.74–5.07). Moreover, the odds of undernutrition was more likely among patients with CD4 cell count of <200 cells/mm3 (AOR = 2.0, 95% CI, 1.38–2.47) and patients with a functional status of bedridden (AOR = 3.6, 95% CI, 1.55–8.35) and ambulatory (AOR = 2.4, 95% CI, 1.66–3.51), respectively.

Conclusion

Both undernutrition and overweight or obesity were prevalent among HIV/AIDS patients in Jimma Medical Center, Ethiopia. Undernutrition was significantly associated with clinical outcome of patients. Hence, nutritional assessment, care and support should be strengthened. Critical identification of malnourished patients and prompt interventions should be undertaken.

Introduction

Human immune deficiency virus (HIV) and malnutrition has multifaceted and multidirectional relationships. Both are related each other in causing progressive damage to the immune system. HIV compromises nutritional status and poor nutrition further weakness the immune system of individuals, increasing susceptibility to opportunistic infections. HIV can cause or worsen malnutrition by triggering reduced food uptake, increased energy requirements and poor nutrient absorptions [13].

Poor nutritional status is one of the major complications of HIV and a significant factor in a full-blown AIDS. In most resource limited settings, many people who become infected with HIV may already be undernourished due to factors such as unemployment and difficulty to procure food. Food insecurity and malnutrition remained the major challenge in the progresses made to avert morbidity and mortality attributed to HIV/AIDS. Food insecurity contributes to high risk sexual behaviors, inconsistent condom use and multiple partnership. While, malnutrition leads to ART non-adherence among HIV/AIDS patients [4,5].

In Sub-Saharan Africa region, malnutrition (both undernutrition and overweight) was prevalent among HIV/AIDS patients enrolled in care [68]. The prevalence of adult undernutrition was 19% in Tanzania [6], 10% in Zimbabwe [7] and 19% in Senegal [9]. The prevalence of malnutrition was also high in Ethiopia; 25.2% in Butajira hospital [10] and 12.3% in Dilla university hospital [11]. The main determinants of malnutrition ranges from individual level factors to underlying factors. The high prevalence of malnutrition was determined by wealth index and educational attainment, where malnutrition decreased with increase in wealth index and educational attainment [12]. A lower CD4 cell count, sex, age, advanced HIV diseases, presence of opportunistic infections, adherence concern, inability to access food and having social support were also significantly associated with malnutrition [6,7,9,13]. Malnutrition is less likely in females and older ages (35–44 years and ≥45 years) compared to 15–24 years. Having social support and informal care giving has also reduced the odds of undernutrition [13]. On the contrary, malnutrition is more likely in those who had advanced HIV disease [6,7,9].

Despite remarkable efforts are made in increasing the treatment coverage of HIV/AIDS in the past decades, the high prevalence of HIV/AIDS and malnutrition has remained the major challenges of health systems in SSA region [14]. This was commonly attributed to the low treatment effectiveness due to factors such as non-adherence, quality and nutritional status of patients [15,16].

Ethiopia has also significantly improved the treatment coverage in the past decades and as the consequence of this promising results were observed. HIV/AIDS treatment coverage was reached to 71% in 2017. Between 2000 and 2017, new HIV infections were reduced by 90% and AIDS related mortality was reduced among adults by more than 50% [17].

However, HIV/AIDS prevalence remained high (0.9%) in Ethiopia [18] and in 2017 there were an estimated 613,000 people living with HIV/AIDS (out of which 29% were lacked access to treatments). Ethiopia is one among the 25 countries worldwide and 17 countries in Africa region with the highest number of new HIV infections [17]. This calls for attention in improving the treatment effectiveness of existing HIV/AIDS services and one of the focus areas of this actions was strengthening the nutritional assessment, care and support services for HIV/AIDS patients. Hence, this study was aimed to estimate the prevalence of malnutrition (undernutrition and overweight or obesity) among adult HIV/AIDS patients enrolled in HIV/AIDS care in the period between 2010 and 2016 at Jimma Medical Center, a tertiary hospital in Ethiopia with an established HIV/AIDS treatment program. We also identified the predictors of undernutrition among HIV/AIDS patients.

Materials and methods

Study setting

Jimma Medical Center, formerly known as Jimma University Specialized Hospital, was one of the teaching hospitals in Ethiopia located in Jimma city administration, 355km Southwest direction of the capital city, Addis Ababa. It is a government hospital which is an affiliate of Jimma University providing trainings for health science students in a range of disciples. The hospital also provides a higher level of clinical care for around 15 million catchment population located in Southwest part of Ethiopia. The hospital has 36 departments, of which ART clinic was one among them. Since 2005, the hospital has been providing highly active antiretroviral therapy (HAART) for people living with HIV/AIDS (PLWHA). During the study period (July 2010 to January 2016), a total of 5554 patients were on HAART.

Study design

Facility based cross-sectional study design was conducted. Data were collected retrospectively from clinical records of HIV/AIDS patients enrolled for follow-up care in ART clinic from July 2010 to January 2016. We retrieved data from patient cards and ART log books of adults (>15 years) from March to April 2016.

Study participants selection

The study participants were cohort of adult HIV/AIDS patients (age >15 years old) on follow-up care. The sample size was computed using OpenEpi Version 3 sample size calculator for proportions by using assumptions of a 95% CI, the outcome factor in the population of 46.8% [19], margin of error 3% and design effect of(DEFF) of 1. The calculated sample size yields 1062.

Sample size formula (n) = [DEFF*Np (1-p)]/ [(d2/Z21-α/2*(N-1) +p*(1-p)]; where DEFF was design effect and Np was the prevalence of outcome variable in the population (i.e., the prevalence of malnutrition).

The study participants were selected by using a systematic sampling strategy; where the clinical records of ART clients from July 2010 to January 2016 were used as a sampling frame. First, a sequential number starting from 1001 were provided to each records. The first record of a patient was selected using lottery method and every Kth records (K = 5) were included. The value of K was obtained by dividing the total ART patients (5554) for the sample size (n = 1062).

HIV/AIDS patients who have a follow-up care in the same facility and that have key baseline information’s such as demographic characteristics (age, ethnicity, and marital status) and clinical information (such as CD4 count, viral load, WHO clinical stage, weight, height, and hemoglobin level) were eligible for this study. In case when records have missed information on one of the variables, it was excluded.

Measurement

A data collection tool, having the same structure with ART register and patient cards, was used to collect data. The tool comprised of components such as patient background information’s, immunologic status, clinical and laboratory examinations (CD4 count, viral load, WHO clinical stage, weight, height) and antiretroviral regimen and opportunistic infection prophylaxis. Three clinicians who had also trained on ART service provision were recruited for data collection. Furthermore, one supervisor with background of health was recruited and monitored the overall process of data collection.

Data were collected from ART unit of the hospital in the following processes. First, data collectors approached the unit and obtained permission. Following this, patient records between July 2010 to January 2016 were retrieved from catalogs and the first patient record was selected randomly. In case when the selected patient record had incomplete information, it was dropped and the next patient record was included and reviewed. The data collection process was continued in such a way until the final sample size was attained.

Statistical analysis

Data were checked for consistency and completeness. Then it was entered into epidata version 3.1 and exported to SPSS version 21. Descriptive statistics were conducted and variables were presented using mean, frequencies and proportion. Body Mass Index (BMI) was calculated as weight in kilograms divided by the squares of height in meters (kg/m2). For the initial analysis, BMI was stratified into the WHO criteria: <18.5 (undernutrition), >18.5 to 25 (normal nutrition) and >25 kg/m2 (overweight or obese). In this study both undernutrition (BMI <18.5 kg/m2) and overweight or obesity (BMI>25 kg/m2) were estimated [3]. Independent predictors of adult undernutrition in adult HIV/AIDS patients (such as socio-demographic and clinical characteristics) were determined by using bivariate and multivariate logistic regression analysis. In the bivariate analysis those variables with P-value < 0.05 were considered candidate variables to multivariate logistic regression model. In the multivariate analysis variables with P-value of < 0.05 were considered statistically significant and interpreted.

The covariates of the multivariate analysis were selected using enter method. While, the model fitness (goodness) was assessed by using Wald test for individual variables and maximum likelihood ratio test for the overall model.

Ethical consideration

Research protocol was submitted to the Institute of Health of Jimma university and ethical approval was obtained (Ref no. RPGC/26/2016; March, 2016). Primarily research permission was obtained from authorities of Jimma Medical Center to access patient records for review and informed consent was not obtained from patients due to the difficulty of accessing every patients. We have accessed anonymized patient information that comprised only unique ART number of the patient and other relevant data for research. The confidentiality of all patient information was maintained through use of codes, where we have provided a sequential code to each patients starting from 1001. Paper-based data were kept in a locked cabinet and computer-based data were secured with passwords. Except the research team members, no one could access patient data. Whenever a need arises, patient data will be shared to a third party by following the legal and ethical guidelines.

Results

Out of the total patient records (n = 1062), 357 were undernutrition patient records, 614 were normal nutrition patient records and 91 were overweight patient records. While undernutrition and normal nutrition patient records were considered in the multivariate analysis (n = 971), we reported only the prevalence of overweight patients (n = 91) (“Fig 1”).

Fig 1. Study flow diagram.

Fig 1

Characteristics of patients

Table 1 presented the demographic, socio-demographic and clinical characteristics of patients on HIV/AIDS follow-care by nutritional status (undernutrition, normal nutrition and overweight or obesity).

Table 1. Socio-demographic and clinical characteristics of patients grouped by nutritional status (BMIa) in Jimma Medical Center, Southwest Ethiopia, 2016.

Variable Undernutrition
No (%)
Normal nutrition
No (%)
Overweight or obese
No (%)
Total
No (%)
Gender
 Male 149(42) 241(39) 23(25) 413(39)
 Female 208(58) 373(61) 68(75) 649(61)
Age group (years)
 16-<30 149(42) 253(41) 30(33) 432(41)
 30–39 141(39) 227(37) 33(36) 401(38)
 40–49 51(14) 100(16) 19(21) 170(16)
 >=50 16(4) 34(6) 9(10) 59(6)
Marital status
 Married 156(44) 308(50) 51(56) 515(48)
 Never married/ single 66(18) 98(16) 13(14) 177(17)
 Separated 52(15) 93(15) 5(5) 150(14)
 Divorced 30(8) 52(8) 11(12) 93(9)
 Widowed 53(15) 63(10) 11(12) 127(12)
Religious status
 Muslim 120(34) 188(31) 34(37) 342(32)
 Orthodox 196(55) 369(60) 47(52) 612(58)
 Protestant 39(11) 53(9) 8(9) 100(9)
 Catholic 2(1) 4(1) 2(2) 8(1)
Educational status
 No education 62(17) 126(21) 12(13) 200(19)
 Primary education 160(45) 267(43) 35(38) 462(44)
 Secondary education 102(29) 164(27) 20(22) 286(27)
 Tertiary education 33(9) 57(9) 24(26) 114(11)
Employment status
 Employed 134(38) 293(48) 46(51) 473(45)
 Unemployed 223(62) 321(52) 45(49) 589(55)
Accessed to water supply
 Yes 285(80) 525(86) 76(84) 886(83)
 No 72(20) 89(14) 15(16) 176(17)
Accessed to electricity
 Yes 346(97) 598(97) 90(99) 1034(97)
 No 11(3) 16(3) 1(1) 28(3)
WHOb clinical staging
 Stage one 58(16) 180(29) 44(48) 282(27)
 Stage two 73(20) 215(35) 25(27) 313(29)
 Stage three 154(43) 172(28) 14(15) 340(32)
 Stage four 72(20) 47(8) 8(9) 127(12)
CD4 cell count
 <200 239(67) 303(49) 26(29) 568(53)
 ≥200 118(33) 311(51) 65(71) 494(47)
Functional status
 Ambulatory 112(31) 73(12) 4(4) 189(18)
 Bed ridden 22(6) 9(1) 1(1) 32(3)
 Working 223(62) 532(87) 86(95) 841(79)
Patient past opportunistic infection
 Yes 297(83) 508(83) 68(75) 873(82)
 No 60(17) 106(17) 23(25) 189(18)
HIV/AIDS disclosure status
 Yes 296(83) 549(89) 86(95) 931(88)
 No 61(17) 65(11) 5(5) 131(12)
Accessed to spiritual care giver
 Yes 191(54) 324(53) 43(47) 558(53)
 No 166(46) 290(47) 48(53) 504(47)
Accessed to community HIV support group
 Yes 106(30) 184(30) 26(29) 316(30)
 No 251(70) 430(70) 65(71) 746(70)
Attended HIV related counseling session
 Yes 153(43) 259(42) 51(56) 463(44)
 No 204(57) 355(58) 40(44) 599(56)
Attended HIV related health education session
 Yes 258(72) 486(79) 72(79) 816(77)
 No 99(28) 128(21) 19(21) 246(23)
Diagnosed for active TBc
 Yes 63(18) 65(11) 4(4) 132(12)
 No 294(82) 549(89) 87(96) 930(88)
Adherence concern to ARTd
 Stigma 252(71) 435(71) 64(70) 751(71)
 Afraid of medications (side effects) 44(12) 67(11) 9(10) 120(11)
 Doubt that medications will work 22(6) 38(6) 5(5) 65(6)
 Depressed or anxious 27(8) 54(9) 9(10) 90(8)
 Will forget to take medications 12(3) 20(3) 4(4) 36(3)

aBody Mass Index;

bWorld Health Organization;

cTuberculosis;

dAntiretroviral Therapy

Majority of the patients were female (61%) and in the age group of <30 years (41%). Nearly half (48%) of them were married and a bit over half of them were followers of orthodox religion (58%). While slightly over four in ten (44%) of patients have attended primary education, most (89%) were unemployed (“Table 1”).

With regards to the clinical characteristics, most of patients have disclosed their HIV status to either a friend or family member (88%) and a bit over three-fourth of them have attended HIV related health education sessions previously (77%). Nearly one-thirds of patients were in the WHO clinical stage two (29%) and another 32% of patients were in the WHO clinical stage three at the start of HIV treatment (ART). Moreover, slightly over half (53%) had CD4 cell count <200 and over three-fourth (79%) of the patients had a working functional status.

The mean and median BMI of patients were 19.99 kg/m2 (SD 3.41) and 19.56 kg/m2, respectively. The proportion of undernutrition (BMI<18.5 kg/m2), normal nutrition (BMI 18.5–24.9 kg/m2) and overweight or obese (BMI≥25 kg/m2) patients were 34%, 58% and 9%, respectively. Out of undernutrition patients, severe malnutrition (BMI<16 kg/m2) accounted of 9% (“Fig 2”).

Fig 2. Nutritional status of HIV/AIDS patients on follow-up care at Jimma Medical Center, Southwest Ethiopia, 2016.

Fig 2

Undernutrition was higher in female patients (58%) and patients in the age group of <30 years old (42%). Likewise, the proportion of undernutrition was higher in married (44%), orthodox religion follower (55%), primary education level (45%) and unemployed (62%) patients (“Table 1”).

Looking a closer at the distribution of undernutrition with patients’ clinical characteristics, undernutrition was higher in patients with WHO clinical stage three (43%), patients with a CD4 cell count <200 cells/mm3 (67%) and patients with past opportunistic infections (OI’s) (62%). Whereas, patients who have disclosed their HIV status (83%) and those patients with a working functional status (62%) had a higher proportions of undernutrition.

Overweight or obesity was higher among female patients (75%) and patients in the age group of 30–39 years old (36%). Overweight or obesity was also higher in married (56%), orthodox religion follower (52%) and primary educational level (38%) patients. While nearly half of overweight or obese patients were in the WHO clinical stage one (48%), majority had a CD4 cell count ≥200 cells/mm3 (71%) and working functional status (95%).

Predictors of undernutrition

Table 2 presented the bivariate analysis results of undernutrition and the different independent variables. In the bivariate logistic regression analysis, marital status, employment status, access to water supply, HIV disclosure status, WHO clinical staging, CD4 cell count, functional status, attending HIV related health education sessions and being diagnosed for active TB were associated with undernutrition. These independent variables were candidates for multivariate logistic regression analysis (“Table 2”).

Table 2. Bivariate association of different variables with undernutrition among HIV/AIDS patients on follow-up care in Jimma Medical Center, Southwest Ethiopia, 2016.

Variable Undernutrition
n (%)
Normal nutrition
n (%)
CORa (95% CIb)
Sex
 Male 149(42) 241(39) Ref
 Female 208(58) 373(61) 0.90(0.69–1.18)
Age group (years)
 16-<30 149(42) 253(41) Ref
 30–39 141(39) 227(37) 1.06(0.79–1.41)
 40–49 51(14) 100(16) 0.87(0.58–1.28)
 >=50 16(4) 34(6) 0.79(0.43–1.49)
Marital status
 Married 156(44) 308(50) Ref
 Never married/ single 66(18) 98(16) 1.33(0.92–1.92)
 Separated 52(15) 93(15) 1.10(0.75–1.63)
 Divorced 30(8) 52(8) 1.14(0.69–1.86)
 Widowed 53(15) 63(10) 1.66(1.09–2.51)*
Religious status
 Muslim 120(34) 188(31) Ref
 Orthodox 196(55) 369(60) 0.83(0.62–1.11)
 Protestant 39(11) 53(9) 1.15(0.72–1.85)
 Catholic 2(1) 4(1) 0.78(0.14–4.34)
Educational status
 No education 62(17) 126(21) Ref
 Primary education 160(45) 267(43) 1.22(0.85–1.75)
 Secondary education 102(29) 164(27) 1.26(0.85–1.87)
 Tertiary education 33(9) 57(9) 1.18(0.69–1.99)
Employment status
 Employed 134(38) 293(48) Ref
 Unemployed 223(62) 321(52) 1.52(1.16–1.98)*
Accessed to water supply
 Yes 285(80) 525(86) Ref
 No 72(20) 89(14) 1.49(1.06–2.09)*
Accessed to electricity
 Yes 346(97) 598(97) Ref
 No 11(3) 16(3) 1.19(0.55–2.59)
WHOc clinical staging
 Stage one 58(16) 180(29) Ref
 Stage two 73(20) 215(35) 1.05(0.71–1.57)
 Stage three 154(43) 172(28) 2.78(1.93–4.01)*
 Stage four 72(20) 47(8) 4.75(2.97–7.62)*
CD4 cell count (cells/mm3)
 <200 239(67) 303(49) 2.08(1.59–2.73)*
 ≥200 118(33) 311(51) Ref
Functional status
 Ambulatory 112(31) 73(12) 3.66(2.62–5.11)*
 Bed ridden 22(6) 9(1) 5.83(2.64–12.86)*
 Working 223(62) 532(87) Ref
Patients’ past opportunistic infections
 Yes 297(83) 508(83) 1.03(0.73–1.46)
 No 60(17) 106(17) Ref
HIV/AIDS disclosure status
 Yes 296(83) 549(89) 0.58(0.39–0.84)*
 No 61(17) 65(11) Ref
Accessed to spiritual care giver
 Yes 191(54) 324(53) 1.03(0.79–1.34)
 No 166(46) 290(47) Ref
Accessed to community HIV support group
 Yes 106(30) 184(30) 1.01(0.76–1.35)
 No 251(70) 430(70) Ref
Attended HIV related counseling session
 Yes 153(43) 259(42) 1.03(0.79–1.34)
 No 204(57) 355(58) Ref
Attended HIV related health education session
 Yes 258(72) 486(79) 0.69(0.51–0.93)*
 No 99(28) 128(21) Ref
Diagnosed for active TBd
 Yes 63(18) 65(11) 1.81(1.25–2.63)*
 No 294(82) 549(89) Ref
Adherence concerns to ARTe
 Stigma 252(71) 435(71) Ref
 Afraid of medications (side effects) 44(12) 67(11) 1.13(0.75–1.71)
 Doubt that medications will work 22(6) 38(6) 0.99(0.58–1.73)
 Depressed or anxious 27(8) 54(9) 0.86(0.53–1.41)
 Will forget to take medications 12(3) 20(3) 1.04(0.49–2.15)

aCrude (unadjusted) odds ratio;

bConfidence interval;

cWorld Health Organization;

dTuberculosis;

eAntiretroviral Therapy

*P-value<0.05

Table 3 presented the multivariate logistic regression analysis result. In the multivariate logistic regression analysis, marital status, access to water supply, WHO clinical staging, CD4 cell count and patient functional status were identified as independent predictors of undernutrition (“Table 3”).

Table 3. Multivariate association of different variables with undernutrition among HIV/AIDS patients on follow-up care in Jimma Medical Center, Southwest Ethiopia, 2016.

Variable Undernutrition
No (%)
Normal nutrition
No (%)
CORa (95% CIb) AORc(95% CI)
Marital status
 Married 156(44) 308(50) Ref Ref
 Never married/ single 66(18) 98(16) 1.33(0.92–1.92) 1.31(0.87–1.96)
 Separated 52(15) 93(15) 1.10(0.75–1.63) 0.96(0.62–1.48)
 Divorced 30(8) 52(8) 1.14(0.69–1.86) 1.11 (0.65–1.91)
 Widowed 53(15) 63(10) 1.66 (1.09–2.51)* 1.7(1.03–2.79)*
Employment status
 Employed 134(38) 293(48) Ref Ref
 Unemployed 223(62) 321(52) 1.52(1.16–1.98)* 1.29(0.96–1.74)
Accessed to water supply
 Yes 285(80) 525(86) Ref Ref
 No 72(20) 89(14) 1.49(1.06–2.09)* 1.69(1.16–2.47)*
WHOd clinical staging
 Stage one 58(16) 180(29) Ref Ref
 Stage two 73(20) 215(35) 1.05(0.71–1.57) 0.92(0.61–1.39)
 Stage three 154(43) 172(28) 2.78(1.93–4.01)* 1.99(1.33–2.97)*
 Stage four 72(20) 47(8) 4.75(2.97–7.62)* 2.97(1.74–5.07)*
CD4 cell count cells/mm3
 <200 239(67) 303(49) 2.08(1.59–2.73)* 1.85(1.38–2.47)*
 ≥200 118(33) 311(51) Ref Ref
Functional status
 Ambulatory 112(31) 73(12) 3.66(2.62–5.11)* 2.41(1.66–3.51)*
 Bed ridden 22(6) 9(1) 5.83(2.64–12.86)* 3.59(1.55–8.35)*
 Working 223(62) 532(87) Ref Ref
HIV disclosure status
 Yes 296(83) 549(89) 0.58(0.39–0.84)* 0.75(0.49–1.15)
 No 61(17) 65(11) Ref Ref
Attended HIV related health education session
 Yes 258(72) 486(79) 0.69(0.51–0.93)* 0.80 (0.57–1.13)
 No 99(28) 128(21) Ref Ref
Diagnosed for active TBe
 Yes 63(18) 65(11) 1.81(1.25–2.63)* 0.83(0.53–1.29)
 No 294(82) 549(89) Ref Ref

aCrude (unadjusted) odds ratio;

bConfidence interval;

cAdjusted odds ratio;

dWorld Health Organization;

eTuberculosis

*P-value<0.05

With regards to marital status, being a widow was significantly associated with undernutrition in that undernutrition was about two times more likely among widowed patients than married patients (AOR = 1.7, 95% CI, 1.03–2.79).

The odds of undernutrition was more likely among patients who didn’t access to water supply compared to those patients that did access to water supply (AOR = 1.69, 95% CI, 1.16–2.47).

Undernutrition was about two times and three times more likely among patients in the WHO clinical stage of three (AOR = 1.99, 95% CI, 1.33–2.97) and four (AOR = 2.97, 95% CI, 1.74–5.07) compared to patients in the WHO clinical stage of one, respectively.

HIV/AIDS patients with CD4 cell count <200 cells/mm3 were two times more likely under nourished than patients with CD4 cell count ≥200 cells/mm3 (AOR = 1.85, 95% CI, 1.38–2.47).

Moreover, the odds of undernutrition was more likely among patients with ambulatory (AOR = 2.41, 95% CI, 1.66–3.51) and bedridden (AOR = 3.59, 95% CI, 1.55–8.35) functional status than those patients with working functional status, respectively.

In the bivariate logistic regression analysis, employment status, HIV disclosure status, being diagnosed for active TB and attending HIV related health education sessions were significantly associated with undernutrition. However, the associations of these variables were not maintained after adjusting for all independent variables.

Discussion

This study was primarily intended to estimate the prevalence of undernutrition and identify the potential predictors of undernutrition among adult HIV/AIDS patients who were enrolled on care or who were on ART treatments. It was also aimed to estimate the prevalence of overweight or obesity among adult HIV/AIDS patients.

The study have indicated that the overall prevalence of undernutrition and overweight or obesity were 34% and 9%, respectively. Out of undernutrition, severe malnutrition (BMI<16 kg/m2) accounted of 9%. We found that patients marital status, access to water supply, WHO clinical staging, CD4 cell count and functional status were significantly associated with undernutrition.

The prevalence of undernutrition was higher compared to studies conducted in different parts of Ethiopia; 12.3% in Dilla university hospital [11], 25.2% in Butajira hospital [10], 18.2% in Arba Minch area public health facilities [20], 30% in East Hararghe zone hospitals [21] and 27% in Nekemte referral hospital [22]. Similarly, the prevalence is also much higher compared to studies done in different parts of the world; 19.5% in Tanzania [6], 10% in Zimbabwe [7] and 19.2% in Senegal [9]. The difference in prevalence of malnutrition might be due to difference in socio-economic and other factors that may predispose the community to problem, such as food habit and culture. However, the prevalence of severe malnutrition (BMI<16kg/m2) was comparable to studies done at Tanzania (9%) [6] and Butajira hospital(9%) [10].

In our study undernutrition was higher among female patients than male. This is comparable to other studies done in different parts of Ethiopia; Southern [11] and Eastern Ethiopia [21]. Yet different from studies done in SSA countries [6,7] and slightly higher among male patients in study done in Butajira hospital, Southern Ethiopia [10]. This implies that undernutrition is more common among females and this might be related to the socio-economic status of women, access to information and other predisposing factors that may affect food intake of women in the community [23]. In Ethiopia, most women were already undernourished than men in the general population. For instance, 24% of women aged 15–49 years were anemic and 22% were thin (BMI<18.5 kg/m2) [18]. Further, lower proportion of female were attended school compared to male and the employment status was much higher among men than women. Similarly, most women were not accessed to mass media and internet compared to men [18].

Our study also revealed that, undernutrition was higher in younger, married, primary education level and unemployed patients compared to their counter parts. As the age of patient’s increased, the prevalence of undernutrition was decreased in the study area. This is comparable with studies done in different parts of the world [6,7] and Ethiopia [10,21], where undernutrition is more prevalent among the younger adults and overweight is more prevalent among older patients. Additionally, studies also supports the higher proportion of undernutrition among unemployed patients and patients in the lower educational status [11,24,25]. While studies done in Northern and Southern Ethiopia indicated contradicting finding in which undernutrition was higher in older age [11,26]. Undernutrition was also much higher in patients in WHO clinical stage three and four, CD4 cell count less than 200 cells/mm3 and in patients with a past opportunistic infections. This indicates interlink between HIV infection and poor nutritional status. HIV compromises the nutritional status and poor nutrition further weakens the immune system of individuals, increasing susceptibility to opportunistic infections [2,23,27,28].

In the multivariate logistic regression, patient marital status, access to water supply, WHO clinical staging, CD4 cell count and functional status were statistically associated with undernutrition in the study area. In the binary logistic regression variables such as employment status, being diagnosed for active TB, attending HIV related health education sessions and HIV disclosure status of patients were significantly associated with undernutrition. Though, these variables didn’t show a statistical significant associations while adjusted for other variables.

Our study revealed that, being a widow and poor access to water supply were significantly associated with undernutrition among HIV/AIDS patients. The association between marital status and undernutrition could might be due to the relationship of marital status and household headship and other social and economic status of individuals [23,29]. It might be also related to psychological conditions of individuals, where married patients better follow HIV treatments as they get required supports from their partners. On the other hand, the association of undernutrition and access to water supply is due to the fact that poor sanitation was related to diseases in patients and disease in itself leads to poor nutritional status of individuals [30,31].

HIV/AIDS patients who were in the WHO clinical stage of three and four were two times and three times more likely undernourished compared to those in the WHO clinical stage of one, respectively. Additionally, the odds of undernutrition was more likely among patients with CD4 cell count of <200 cells/mm3 and patients with functional status of bedridden and ambulatory. Undernutrition was nearly four times and two times more likely among bedridden and ambulatory patients compared to patients who have a working functional status, respectively. Our findings were supported by other studies done in other settings else [6,7,10,11,13,20,21,2426].

Undernutrition was the major factor in ensuring treatment effectiveness and thus, nutritional assessments, care and support for HIV/AIDS patients should be strengthened. Poor adherence to HIV treatments or drug is caused by lack of access to food or food insecurity. On the other hand, poor treatment adherence leads to infections and suppressed immunity of patients [9]. Mortality is more likely among immune compromised HIV/AIDS patients and supplementation of therapeutic food can improve the nutritional status of patients [32].

Our study have assessed the prevalence of malnutrition (undernutrition and overweight or obesity) among patients who were enrolled in care in the period between 2010 and 2016. Sufficient sample size was used to estimate the prevalence of both undernutrition and overweight or obesity. Yet, our study has the following limitations. The study was based on secondary data (chart review) and thus, may not address all of the variables that may affect undernutrition and may be subject to incomplete data bias.

Conclusion

This study showed that the prevalence of malnutrition (both undernutrition and overweight) was high compared to other settings in Ethiopia. It was also revealed that WHO clinical AIDS staging three and four, CD4 cell count <200 cells/mm3, functional status, patient marital status and access to water supply were significantly associated with undernutrition among adult HIV/AIDS patients. This calls the government to give due attention to strengthening the HIV/AIDS treatment, care and support services at hospitals. HIV/AIDS treatment services should be supported with nutritional assessment, supplementation, counseling, care and support to patients. A comprehensive nutritional assessment and support should be provided for all patients who are on a follow-up care. Moreover, community support to patients should be strengthened, as social determinants of health may also interact with the effectiveness HIV/AIDS treatments.

Supporting information

S1 File. Minimum data set.

(XLSX)

Acknowledgments

The authors would like to thank Jimma Medical Center administration and Workers at Antiretroviral Therapy (ART) unit for cooperating with and supporting the research work.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The research was awarded by Jimma University Mega Research Project and award was received by DWD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.WHO. Technical Consultation on Nutrient Requirements for People Living with HIV/AIDS (Geneva, Switzerland). 2003.
  • 2.Food and Nutrition Technical Assistance (FANTA). Guide to Screening for Food and Nutrition Services among Adolescents and Adults Living with HIV. 2010.
  • 3.Food and Nutrition Technical Assistance (FANTA). Nutrition Assessment, Counseling, and Support (NACS). Nutrition Assessment and Classification. A User’s Guide. 2016.
  • 4.Gillespie S KS. HIV/AIDS and Food and Nutrition Security: From Evidence to Action. Washington: International Food Policy Research Institute. 2005.
  • 5.Marston BDK. Multivitamins, nutrition, and antiretroviral therapy for HIV disease in Africa. N Engl J Med. 2004;351:78–80. 10.1056/NEJMe048134 [DOI] [PubMed] [Google Scholar]
  • 6.Kabalimu TK, Sungwa E, Lwabukuna WC. Malnutrition and associated factors among adults starting on antiretroviral therapy at PASADA Hospital in Temeke District, Tanzania. J Heal Res. 2018;20[2]. [Google Scholar]
  • 7.Takarinda KC, Mutasa-apollo T, Madzima B, Nkomo B, Chigumira A, Banda M, et al. Malnutrition status and associated factors among HIV-positive patients enrolled in ART clinics in Zimbabwe. BMC Nutr. 2017;3:15. [Google Scholar]
  • 8.Anabwani G, Ch B, Navario P. Nutrition and HIV / AIDS in sub-Saharan Africa : an overview. Rev Artic. 2005;21:96–9. [DOI] [PubMed] [Google Scholar]
  • 9.Benzekri NA, Sambou J, Diaw B, Hadji E, Sall I. High Prevalence of Severe Food Insecurity and Malnutrition among HIV-Infected Adults in Senegal, West Africa. PLoS One. 2015;1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gedle D, Gelaw B, Muluye D, Mesele M. Prevalence of malnutrition and its associated factors among adult people living with HIV / AIDS receiving anti-retroviral therapy at Butajira Hospital, southern Ethiopia. BMC Nutr. 2015;1:5. [Google Scholar]
  • 11.Hailemariam S, Bune GT, Ayele HT. Malnutrition: Prevalence and its associated factors in People living with HIV/AIDS, in Dilla University Referral Hospital. Arch public Heal. 2013;71:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Uthman OA. Prevalence and pattern of HIV-related malnutrition among women in sub-Saharan Africa : a meta-analysis of demographic health surveys. BMC Public Health. 2008;8:226 10.1186/1471-2458-8-226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Negessie A, Jara D, Taddele M, Burrowes S. Determinants of undernutrition among adult patients receiving antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a case-control study design. BMC Nutr. 2019;5:20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.UNAIDS. GLOBAL HIV STATISTICS. Global AIDS Update 2019. 2019.
  • 15.UNAIDS. Fact Sheet on HIV/AIDS. 2016.
  • 16.UNAIDS. HIV/AIDS Prevention Gap Report. 2016.
  • 17.Federal HIV/AIDS Prevention and Control Office. HIV Prevention in Ethiopia. National Road Map (2018–2020). 2018.
  • 18.Central Statistical Agency (CSA) and ICF. Ethiopia Demographic and Health Survey. 2016.
  • 19.Habtamu M, Mulu H, Hamza L, Alemseged F. Prevalence of Malnutrition and Associated Factors among Hospitalized Patients with Acquired Immunodeficiency Syndrome in Jimma University Specialized Hospital, Ethiopia. Ethiop J Heal Sci. 2016;26[3]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Care P, Zemede Z, Estifanos W. Undernutrition and associated factors among HIV-positive adult patients enrolled in antiretroviral therapy (ART) clinics in the Arba Minch area, southern Ethiopia. HIV/AIDS—Res Palliat Care. 2019;11:147–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dedha M, Damena Melake, Egata Gudina N L. Undernutrition and associated factors among adults human immunodeficiency virus positive on antiretroviral therapy in hospitals, East Hararge Zone, Oromia, Ethiopia: A cross-sectional study. Int J Health Sci (Qassim). 2017;11[5]:35–42. [PMC free article] [PubMed] [Google Scholar]
  • 22.kenea Meskerem Alemayehu Garoma Sileshi Habtamu FG. Assessment of Adult Nutritional Status and Associated Factors among ART Users in Nekemte Referral Hospital and Health Center, East Wollega Zone, Ethiopia. Adv Life Sci Technol. 2015;29:91–100. [Google Scholar]
  • 23.Mihretie Y. Review on Factors Affecting the Nutritional Status of Women in Ethiopia. Interv Obes Diabetes. 2018;2[1]:IOD.000526. [Google Scholar]
  • 24.Ab G, Ae G, Db K, Gizaw AB, Eshetu A, Birhanu D. Malnutrition and Associated Factors among Adult People Living with HIV / AIDS Receiving Antiretroviral Therapy at Organization for Social Service Health Development in Jimma Town Oromia Region South West. Gen Med (Los Angeles), an open access. 2018;6[2]:4–11. [Google Scholar]
  • 25.Gebremichael DY, Hadush KT, Kebede EM, Zegeye RT. Food Insecurity, Nutritional Status, and Factors Associated with Malnutrition among People Living with HIV / AIDS Attending Antiretroviral Therapy at Public Health Facilities in West Shewa Zone, Central Ethiopia. Biomed Res Int. 2018;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sewale Y, Hailu G, Sintayehu M, Moges NA, Alebel A. Magnitude of malnutrition and associated factors among HIV infected children attending HIV—care in three public hospitals in East and West Gojjam Zones, Amhara, Northwest, Ethiopia, 2017: a cross—sectional study. BMC Res Notes. 2018;11:788 10.1186/s13104-018-3882-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Garcia-prats AJ, Mcmeans AR, Ferry GD, Klish WJ. Nutrition and HIV / AIDS. HIV Curriculum for the health professional. p. 286–307.
  • 28.Ezinna E. Enwereji MCE and PENO. Basic Principles of Nutrition, HIV and AIDS: Making Improvements in Diet to Enhance Health. Nutrition and HIV/AIDS—Implication for Treatment, Prevention and Cure treatment.
  • 29.Woldemariam GTG. Determinants of the Nutritional Status of Mothers and Children in Ethiopia. Calverton, Maryland, USA: ORC Macro. Calverton, Maryland,. 2002. [Google Scholar]
  • 30.Departement of technique action centre la FAIM-Fr. Interactions of: Malnutrition, Water Sanitation and Hygiene, Infections. Action Faim. 2007.
  • 31.Wondimu M. Examining the Impact of Household Access to Water and Sanitation on Child Malnutrition in Ethiopia. A Thesis Submitted to the Graduate Faculty of Georgia State University in Partial Fulfillment of the Requirements for the Degree. 2016.
  • 32.Mallewa J, Szubert AJ, Mugyenyi P, Chidziva E, Thomason MJ, Chepkorir P, et al. Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. Lancet HIV. 2018;5[May]:231–40. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Simeon-Pierre Choukem

13 Dec 2019

PONE-D-19-30011

Prevalence of malnutrition and associated factors among adult patients on Antiretroviral Therapy follow up care in Jimma Medical Center, Southwest Ethiopia.

PLOS ONE

Dear Mr. Daka,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Be sure to:

We recommend you pay specific attention to major comments from reviewer 1, and address them

We would appreciate receiving your revised manuscript by Jan 27 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Simeon-Pierre Choukem

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records/samples used in your retrospective study. Specifically, please ensure that you have discussed whether all data/samples were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data/samples from their medical records used in research, please include this information.

3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: General

The article address a major issue among HIV infected patients, especially in Africa and other low income settings. The study hypothesis and objectives are well stated. The authors have evaluated the prevalence and risk factors of under nutrition among patients receiving ART at a university hospital in Ethiopia. They found a high (36%) prevalence of under nutrition ; associated with marital status (widow), advance WHO clinical stage (III-IV), and low CD4 count (<200 cell/ul). While this topic has already being studied in several settings, local data are crucial to design local actions.

Major comments

The reference to malnutrition is sometimes confusing as it include both undernutrition and overweight. Reader may feel more comfortable if authors focus on undernutrition (the main topic of the study). This could be stated already in the title.

Authors state malnutrition as The main problem among people living with HIV. Maybe this statement could be attenuated, indicating food security and under nutrition as a major threat to HIV programs.

It would have been interesting to have information about diet, food security and incomes (eg. Wealth index) as these factors are known to affect nutritional status. Advance HIV status and low cd4 count found in this study, as well as under nutrition, may all be surrogates of poverty or deficient diet.

With the high prevalence (55.8%) of patients with less than 200 CD4, it would be interesting to indicate the prevalence of patients in treatment failure. The observed severe under nutrition could be a wasting syndrome related to a treatment failure and disease progression.

The study design is stated as cross-sectional. Readers may have difficulties to understand the patients inclusion process. It may be useful to clarify this section, especially the used "lottery method" (random selection ?) and the "Kth records identified for abstraction", lines 111-113.

The authors seem to make a confusion between prevalence in a study group and weight of the group within the whole population. Thus, most of the undernourished being married (table 3) does not necessarily mean that undernutrition is most prevalent among married as stated at line 173. This mistake apply to other variables mentioned in the paragraph "Prevalence of malnutrition". Conversely, in paragraph addressing factors associated with malnutrition, authors should use "proportion" instead of "number" (line 186 and beyond).

Table 1,2 and 3 can be merged to keep only two tables, with 3 results columns each: 1- Normal nutritional status, 2- Under nutrition and 3- total

To ensure easy reading of the paper, English language should be improved.

Minor comments

Details about countries prevalence and the risks factors of malnutrition discussed in the introduction (lines 58-60 and 63-69) would be more useful in the discussion

Line 151: Readers may be interested to know why 9% of the records were not completed (missing data?)

Line 54: Food insecurity (and not malnutrition by itself) increases high risk sexual behaviors

Line 72: author may state the overweigh is also "a major" problem and not "the main"

Line 121: "data abstraction tool" here probably refer to a "data collection tool"

Line 142: the section about patients confidentiality may be simplified.

Reviewer #2: No research has been done to this scope, wide range of duration and large sample size in Ethiopia. Because of limited number of researches are there to establish volume of evidences for different contradicting findings regarding the factors, it contributes to conduct valid systematic review and Meta analysis. The authors should revisit the method section so that it will be clear for readers. Write population, inclusion and exclusion criteria and the analysis section clearly. Let the language experts edit the manuscript. Discussion should address some plausible scientific explanation in addition to comparison. Finally if these comments are refined, I wish it will be accepted publication.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-19-30011_reviewer (1).pdf

PLoS One. 2020 Mar 12;15(3):e0229883. doi: 10.1371/journal.pone.0229883.r002

Author response to Decision Letter 0


22 Jan 2020

We appreciate the comments provided by the editor and reviewers on the original research article submitted to PLOS ONE. In this letter we would like to provide our responses both for the comments provided by the editor and the reviewers separately.

Response to the Editor:

A per the comments provided by the Editor, we have modified the formats of the manuscript (the Title page and tables/figures) to be compatible with the PLOS ONE guidelines.

Regarding to the ethics statement, all patient’s data were initially anonymized in that we have accessed all patient records with only their unique ART number. Though, as this unique ART number might let identification of patients; patient data were collected by using unique codes for each records starting from 1001. As data were collected from secondary sources (patient records), we were unable to take informed consent from each patients. Instead, we have obtained a permission from authorities of the Medical Center based on the approval letter received from the Ethical Review Committee. The requirements of informed consent was waived by the IRB or ethics committee.

With regards to data sharing, we have included the de-identified or anonymized patient data into the supplementary information’s. The format of data included in the supplementary information’s was excel or spreadsheets.

Finally, the corresponding author have created ORCID iD and it was validated by Editorial manager.

Response to the reviewers:

Response to reviewer 1:

The main aim of this article was to estimate the prevalence of undernutrition and identify the predictors of undernutrition in adult HIV/AIDS patients on follow-up care. We have also estimated the prevalence of overweight or obesity among HIV/AIDS patients. This is the reason why we have defined the title as the prevalence of malnutrition instead of undernutrition and we repeatedly utilized the term malnutrition in the manuscript.

We have addressed the detail description of the study methods (study design, study population and participant’s selection processes) in the methods and materials section of the current or revised manuscript. In addition we have also clearly presented the study participation in the results section of the manuscript with support of the study flow diagram (Fig 1). Out of the total study participants (n=1062), normal nutrition, under nutrition and overweight or obesity accounted of 614, 357 and 91; respectively. The missing data (9%) in the previous version of the manuscript was observed as we didn’t clearly indicate the denominator in estimating overweight or obesity (lack of clarity in data presentation). Overall, in this version of the manuscript; we tried to adequately address the comments provided in the methods and results section by the reviewer.

As we have used secondary data for this specific article and only limited variables were included, we didn’t assess the food insecurity and wealth index of patients. Hence, the variables addressed were limited to the one presented in this article/manuscript.

We have addressed the comments provided in the results section. We have merged table 1, 2 and 3. Hence, the total number of tables in the manuscript was reduced to 3. We have also incorporated the comments provided in the ‘Prevalence of malnutrition’ sub-heading of the Results section of the manuscript. Additionally, we have also addressed the minor comments provided by the reviewer.

Response to reviewer 2:

Most of the comments provided by the reviewer are related to the clarity of the method section and language. In the revised version of the manuscript, we have clearly presented the study methods (including the study design, study population, sampling, inclusion/exclusion criteria and analysis). We have also revised the language.

Kindly regards,

Attachment

Submitted filename: Reponse to Reviewers.docx

Decision Letter 1

Simeon-Pierre Choukem

19 Feb 2020

Prevalence of malnutrition and associated factors among adult patients on Antiretroviral Therapy follow-up care in Jimma Medical Center, Southwest Ethiopia.

PONE-D-19-30011R1

Dear Dr. Daka,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Simeon-Pierre Choukem

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Simeon-Pierre Choukem

25 Feb 2020

PONE-D-19-30011R1

Prevalence of malnutrition and associated factors among adult patients on Antiretroviral Therapy follow-up care in Jimma Medical Center, Southwest Ethiopia.

Dear Dr. Daka:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Simeon-Pierre Choukem

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Minimum data set.

    (XLSX)

    Attachment

    Submitted filename: PONE-D-19-30011_reviewer (1).pdf

    Attachment

    Submitted filename: Reponse to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES